or Try an Advanced Search...

    Plaque Psoriasis Stocks List

    Symbol Grade Name % Change
    ARQT D Arcutis Biotherapeutics, Inc. 0.88
    BIIB C Biogen Idec Inc. 0.23
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Immunology Psoriasis Alopecia Areata Alzheimer's Disease Atopic Dermatitis Atopy Autoimmune Disease Autoimmune Disorders Biotechnology Cd20 Chronic Lymphocytic Leukemia Clinical Trial Product Clinical Trial Products Degenerative Disease Dermatitis Dermatological Diseases Disability Eczema Hemophilia Idiopathic Pulmonary Fibrosis

    Related ETFs - A few ETFs which own one or more of the above listed Plaque Psoriasis stocks.

    Symbol Grade Name Weight
    BIS D ProShares UltraShort Nasdaq Biotechnology 6.12
    PBE C PowerShares Dynamic Biotech & Genome 5.07
    IBRN D iShares Neuroscience and Healthcare ETF 4.68
    BBH C Market Vectors Biotech ETF 4.58
    MNTL D Tema Neuroscience and Mental Health ETF 4.26
    View all Plaque Psoriasis ETFs...
    Compare ETFs
    Compare BIS to MNTL Compare BIS to PBE Compare IBRN to MNTL

        Plaque Psoriasis Stocks Recent News

        Date Stock Title
        May 17 BIIB Ionis, Biogen Down on Ending Development of ALS Drug
        May 17 BIIB Ionis (IONS), Biogen Down on Ending Development of ALS Drug
        May 16 BIIB Biogen also drops collaboration with Ionis on Angelman syndrome candidate
        May 16 BIIB Biogen and Ionis drop ALS candidate after trial setback
        May 16 BIIB Biogen, Ionis shelve ALS drug following study failure
        May 16 BIIB REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
        May 16 BIIB Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 16 BIIB Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 15 ARQT Q1 2024 Arcutis Biotherapeutics Inc Earnings Call
        May 15 BIIB Eisai projects major growth for Alzheimer's therapy Leqembi
        May 15 BIIB Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
        May 15 ARQT Arcutis Biotherapeutics surges 22% on Q1 beats
        May 15 BIIB Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
        May 15 BIIB Eisai sets new revenue target for Alzheimer’s drug Leqembi
        May 15 ARQT Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
        May 15 BIIB Biogen partner Eisai begins FDA submissions for injectable Alzheimer’s therapy
        May 15 ARQT Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
        May 15 BIIB UPDATE 1-Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
        May 14 ARQT Arcutis Biotherapeutics, Inc. (ARQT) Q1 2024 Earnings Call Transcript
        May 14 BIIB Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Immunology Psoriasis Alopecia Areata Alzheimer's Disease Atopic Dermatitis Atopy Autoimmune Disease Autoimmune Disorders Biotechnology Cd20 Chronic Lymphocytic Leukemia Clinical Trial Product Clinical Trial Products Degenerative Disease Dermatitis Dermatological Diseases Disability Eczema Hemophilia Idiopathic Pulmonary Fibrosis
        Plaque Psoriasis

        Plaque psoriasis is a chronic autoimmune skin condition that causes raised, red, scaly patches to appear on the skin. It is the most common form of psoriasis, affecting around 80% of people with the condition. Plaque psoriasis can appear anywhere on the body, but is most commonly found on the elbows, knees, scalp, and lower back.

        Browse All Tags